Abstract: 

On one side, we hear reports pharma and healthcare industry is lagging as opposed to some of the other industries like Retail, Telecom and technology and on other side we hear new innovations, digital therapies, new products being launched in pharma and healthcare – as a data science practitioner, have you ever wondered why is there a contrast? Listen to this talk on some reflections on the various elements on what those could be and any impact on the journey due to the pandemic.

Bio: 

Debashish is ex-Deloitte Consulting Managing Director and has more than two decades of experience in A variety of emerging technologies of IR4.0 specifically in data science and artificial intelligence. Currently he heads Innovation and Strategy at GDD India, aimed to provide thought leadership, enable and execute some of the marquee, transformative and strategic initiatives of Novartis. Instrumental in establishing the corporate innovation accelerator - Biome in India for Novartis – which aim is to provide collaboration opportunities with the start-up ecosystem. Deba has extensive work experience in many geographies including, USA, South Korea, Australia, UK, Germany, Denmark and India. He is a voracious reader, traveler and speaker. His publications and thought ware, has been recognized by many industry and academic conferences across India, Japan and USA. Deba has received many industry accolades e.g. Golden Leadership award in 2016 from Amity University. Analytics India Magazine has named him as one of the top 10 analytics and data science leader in India. He is also serving as a Board of Advisor for TropoGo- a first of its kind - Drone Marketplace start-up. Deba serves as an Industry Advisor for Indian School of Business (ISB).